The Centers for Medicare and Medicaid Services (CMS) and pharmaceutical drug manufacturers are gearing up for the second ...

Over 40% of U.S. adults meet the medical classification for obesity, according to the Centers for Disease Control and ...

Last year was a pivotal year for the pharmaceutical industry. Under the IRA’s Medicare Drug Price Negotiation Program (the ...

The new MC20 GT2 Stradale looks like the ultimate Italian race car for the road, but is it a true competitor for the 911 GT3 ...

US sweet protein startup Oobli has raised $18M and partnered with global ingredients giant Ingredion to develop ...

Novo Nordisk A/S shares are on track for their worst week this year, after a Super Bowl advertisement touting copycat ...

Over $600 billion in European goods were imported by the U.S. last year. New tariffs from President Trump will likely hit these popular categories the hardest.

Hims & Hers wants to keep on selling a compounded version of Ozempic. And it's channeling anti-establishment vibes to make its case.

Most Americans would prefer brand-name drugs—but end up buying generic versions because of the cost, new consumer research ...

Zealthy and Ro both offer FDA-approved, generic GLP-1s at personalized dosages to fit your needs. These platforms also have a ...

A new study suggests that medications that have transformed the treatment of obesity may also help people drink less alcohol.

Hyundai has revealed the UK pricing and specifications for its new beefy Inster Cross model, which is now available to order.